Dealing with the itchy, scaly patches that come with psoriasis is difficult enough. But having psoriasis puts you at risk of ...

Psoriatic arthritis (PsA) is less common among Black people compared to other races, but differences in prevalence may also ...

A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Sponsored by Takeda As a Black doctor specializing in psoriatic arthritis (PsA), I have noticed the difficulties in ...

If psoriasis runs in your family, you may carry the genes—but lifestyle choices and early care can make all the difference in ...

Kayakalp Global, an integrative dermatology center, announced positive in vitro lab results for its Psorcure Oil, a steroid ...

Icotrokinra is currently being developed through a licensing and collaboration agreement between Protagonist and J&J.

Although psoriasis doesn’t necessarily cause metabolic syndrome, patients with the inflammatory condition have a higher rate of the comorbidity, which includes increased belly fat, insulin ...

Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque ...

The likelihood of reduced quality of life and high symptom burden in patients with psoriasis was similar across those with low, medium, and high BSA.

One of the more serious side effects from immune checkpoint inhibitor (ICI) therapies for cancer is new-onset or worsened ...